Phil Perry Retires: Impact on 340B Program Litigation and Regulation
Phil Perry's retirement signals notable changes in 340B litigation as CMS proposes a new rule impacting drug payments; public comment open through August 2026.
Phil Perry's retirement signals notable changes in 340B litigation as CMS proposes a new rule impacting drug payments; public comment open through August 2026.
Explore how proposed changes to federal financial assistance could impact healthcare grants and the essential services they fund, emphasizing stability and accountability.
Discover significant updates to Medicare Part D coming in 2026, including a $2,100 cap on out-of-pocket expenses and new drug price negotiation strategies.
ACCP's lobbying efforts focus on Medicare coverage of pharmacy services and medication safety, advocating for essential healthcare policies.
Explore the success of ACO REACH and the upcoming ACO LEAD model. Learn how these initiatives impact Medicare's financial health and patient care.
Tonix Pharmaceuticals expands Medicare coverage for TONMYA®, improving access for 9M beneficiaries. Discover innovations in fibromyalgia treatments.
Explore the push for Medicare coverage of grab bars to prevent falls among older adults. Understand the financial implications and safety benefits today.
Discover how the new Medicare GLP-1 Bridge program improves access to weight loss medications for millions of Americans. Learn more about eligibility and benefits.
Explore the need for Medicare coverage of grab bars to prevent falls among seniors. Learn about lobbying efforts and essential stats for fall injury prevention.
Explore how OIG investigations are reshaping healthcare compliance and insurance risk management. Stay informed on critical regulatory updates that affect stakeholders.